Statement of the Inter-Ministerial Committee on the National Dialogue on the state of readiness for the first National Convention



West Africa Advances Lassa Fever Vaccine Research Amid Rising Cases Abuja, Nigeria, August 14, 2025 – As Lassa fever continues to claim lives across West Africa, with Nigeria alone reporting 717 confirmed cases and 138 deaths in the first five months of 2025, regional and global efforts are intensifying to develop a vaccine and bolster research capacity. The viral hemorrhagic fever, endemic to countries like Nigeria, Ghana, Liberia, and Sierra Leone, underscores the urgent need for sustained investment in vaccine development and local manufacturing to curb its devastating impact. Breakthroughs in Vaccine Development A significant milestone was announced in June 2025 by Nigerian virologist Dr. Simeon Agwale of Innovative Biotech. His team developed a Lassa fever vaccine based on a Nigerian strain, achieving 100% protection in preclinical trials on mice and non-human primates. Licensed from Medigen USA, the vaccine is poised for Phase 1 clinical trials, pending upgrades to manufacturing facilities to meet Good Manufacturing Practice (GMP) standards. Globally, the Coalition for Epidemic Preparedness Innovations (CEPI) is supporting multiple vaccine candidates. The IAVI-developed rVSV-based vaccine, modeled on the Ebola vaccine platform, is now in Phase 2a trials across Nigeria, Ghana, and Liberia, enrolling over 600 participants to evaluate safety and immune response. Results are expected later in 2025. Additionally, Oxford University’s ChAdOx1 vaccine, leveraging the same platform as the Oxford/AstraZeneca COVID-19 vaccine, entered Phase 1 trials in London in early 2025, with plans to expand to West Africa. Building Research and Trial Capacity West Africa is strengthening its capacity to lead vaccine trials through regional collaboration and infrastructure development. The CEPI-funded Enable study, the largest Lassa fever research effort to date, is generating critical epidemiological and sero prevalence data to guide trial design and site selection. The study also enhances local infrastructure, improving cold-chain systems, laboratory diagnostics, ethical review processes, and data management. The West Africa Health Organization (WAHO) leads the Lassa Vaccine Coalition, uniting governments, researchers, and regulators across Nigeria, Sierra Leone, Liberia, and beyond to align vaccine development with regional needs. In Nigeria, the Lassa Vaccine Task Force, launched in 2023, coordinates efforts between the Nigeria Centre for Disease Control (NCDC) and the National Agency for Food and Drug Administration and Control (NAFDAC).Training programs are fostering a new generation of researchers. The Vanderbilt-Nigeria V-BRCH program and Nigeria’s Field Epidemiology Training Programme (NFETP) are equipping scientists with skills in ethics, Good Clinical Practice, and outbreak response. The Kano Independent Research Centre Trust (KIRCT) serves as a model trial site with advanced laboratories and community engagement systems.Manufacturing Challenges PersistDespite scientific progress, West Africa faces significant hurdles in vaccine manufacturing. While Senegal’s Institut Pasteur de Dakar leads regional production, most countries, including Nigeria, rely on imported vaccines. Nigeria’s National Veterinary Research Institute produces livestock vaccines but lacks GMP-compliant facilities for human vaccines. High costs, scarce raw materials, and inadequate infrastructure hinder progress toward WHO prequalification.Nigeria’s Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) aims to address these gaps by mobilizing investment and enhancing local manufacturing. However, a shortage of skilled researchers and outdated training curricula remain barriers. Traditional fellowships often fail to build sustainable research ecosystems, and limited mentorship and career pathways risk losing talent.A Path to Self-RelianceWith promising vaccine candidates and growing research capacity, West Africa is poised to shift from vaccine dependency to leadership in combating Lassa fever. Sustained investment in training, trial infrastructure, and manufacturing, alongside robust community engagement to address vaccine hesitancy, will be critical to success. As global and regional efforts converge, countries like Nigeria are laying the foundation for a future where they can independently tackle Lassa fever and other endemic threats.

Double Standards in Justice: Communicating Fairness to Win Investor Confidence in Africa
By: Musa Sanusi Ahmad
“Justice must not only be done, but must also be seen to be done.” These words echo louder in Africa
today, as the continent finds itself grappling with the dual challenge of building investor confidence
while confronting the persistent perception, and reality, of double standards in justice.
In the last two decades, Africa has made significant progress in becoming an attractive destination for
global investment. From fintech in Nigeria to renewable energy in Kenya and minerals in the Democratic
Republic of Congo, the continent is bursting with opportunity. Yet, a nagging issue continues to cloud
investor sentiment: the perception that justice is selective, political interference is rampant, and legal
protections for businesses vary depending on who holds the power.
The Double Standard Dilemma
Across many African jurisdictions, the justice system is seen as skewed, often favoring the politically
connected while foreign or minority investors find themselves vulnerable to abrupt policy reversals,
opaque legal proceedings, and bureaucratic stonewalling.
Consider the examples:
In some countries, multinational corporations have faced asset seizures or retrospective tax bills
without due process.
Local entrepreneurs with less political clout often face insurmountable legal delays when
contesting unjust regulatory actions.
In corruption probes, foreign investors are sometimes made scapegoats, while local facilitators
escape scrutiny.
This inconsistency breeds caution. For institutional investors and global corporations, rule of law and fair
arbitration are as critical as market potential. Without predictable legal recourse, financial risk increases,
and so do insurance premiums and exit plans.
The Role of Communication in Restoring Trust
This is where strategic communication comes in. It’s no longer enough for governments and business
regulators to claim reform. They must communicate it effectively, credibly, and consistently.
Here’s how PR and communications professionals can bridge the trust gap:
1. Transparency Campaigns Rooted in Evidence
Regulatory bodies and justice departments should launch proactive campaigns showcasing data-backed
improvements: number of investor disputes resolved fairly, timeframes of legal recourse, and
independent rulings against government interests. Communication must be supported by real reform,
not just polished messaging.
2. Third-Party Validation
Credible third parties, international law firms, arbitration bodies, or NGOs—can validate justice system
improvements. Quotes, reports, and endorsements from these organizations can be leveraged in media
relations and investor briefings to shift the narrative from skepticism to cautious optimism.
3. Narrative Framing Around Fairness, Not Just Growth
Africa’s communications about investment have often leaned too heavily on GDP stats and untapped
markets. Today’s investors want assurance of ethical conduct, ESG compliance, and fair business
treatment. Reframing the narrative to emphasize judicial reform, investor protection, and anti-
corruption milestones is critical.
4. Real-Time Crisis Communication
When disputes arise, silence is the enemy. Governments and investment promotion agencies must
respond promptly, providing timelines for resolution and clear legal pathways. A proactive, respectful
stance signals institutional maturity, even amidst tension.
The Strategic Advantage of Fairness
For Africa to truly rise as a global investment powerhouse, it must not only be rich in resources, it must
be rich in rules that are consistently applied. In a world where capital is increasingly values-driven,
perceptions of fairness can move markets.
Justice and investment are deeply intertwined. And in the realm of international business, perception is
reality. PR and communications professionals are uniquely positioned to help African institutions
communicate fairness, not as a spin strategy, but as a pillar of sustainable development and investor
trust.
Because in the long game of economic reputation, integrity always outperforms impulse.